Literature DB >> 19204222

Overrides of medication alerts in ambulatory care.

Thomas Isaac1, Joel S Weissman, Roger B Davis, Michael Massagli, Adrienne Cyrulik, Daniel Z Sands, Saul N Weingart.   

Abstract

BACKGROUND: Electronic prescribing systems with decision support may improve patient safety in ambulatory care by offering drug allergy and drug interaction alerts. However, preliminary studies show that clinicians override most of these alerts.
METHODS: We performed a retrospective analysis of 233 537 medication safety alerts generated by 2872 clinicians in Massachusetts, New Jersey, and Pennsylvania who used a common electronic prescribing system from January 1, 2006, through September 30, 2006. We used multivariate techniques to examine factors associated with alert acceptance.
RESULTS: A total of 6.6% of electronic prescription attempts generated alerts. Clinicians accepted 9.2% of drug interaction alerts and 23.0% of allergy alerts. High-severity interactions accounted for most alerts (61.6%); clinicians accepted high-severity alerts slightly more often than moderate- or low-severity interaction alerts (10.4%, 7.3%, and 7.1%, respectively; P < .001). Clinicians accepted 2.2% to 43.1% of high-severity interaction alerts, depending on the classes of interacting medications. In multivariable analyses, we found no difference in alert acceptance among clinicians of different specialties (P = .16). Clinicians were less likely to accept a drug interaction alert if the patient had previously received the alerted medication (odds ratio, 0.03; 95% confidence interval, 0.03-0.03).
CONCLUSION: Clinicians override most medication alerts, suggesting that current medication safety alerts may be inadequate to protect patient safety.

Entities:  

Mesh:

Year:  2009        PMID: 19204222     DOI: 10.1001/archinternmed.2008.551

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  110 in total

1.  High-priority drug-drug interactions for use in electronic health records.

Authors:  Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2012-04-26       Impact factor: 4.497

2.  Rights and responsibilities of users of electronic health records.

Authors:  Dean F Sittig; Hardeep Singh
Journal:  CMAJ       Date:  2012-02-13       Impact factor: 8.262

3.  Prescribers' expectations and barriers to electronic prescribing of controlled substances.

Authors:  Cindy Parks Thomas; Meelee Kim; Ann McDonald; Peter Kreiner; Stephen J Kelleher; Michael B Blackman; Peter N Kaufman; Grant M Carrow
Journal:  J Am Med Inform Assoc       Date:  2011-09-21       Impact factor: 4.497

4.  A multi-lingual web service for drug side-effect data.

Authors:  Steven D Bedrick; Alejandro Mauro
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

5.  Randomized clinical trial of a customized electronic alert requiring an affirmative response compared to a control group receiving a commercial passive CPOE alert: NSAID--warfarin co-prescribing as a test case.

Authors:  Brian L Strom; Rita Schinnar; Warren Bilker; Sean Hennessy; Charles E Leonard; Eric Pifer
Journal:  J Am Med Inform Assoc       Date:  2010 Jul-Aug       Impact factor: 4.497

6.  Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions.

Authors:  Kim R Saverno; Lisa E Hines; Terri L Warholak; Amy J Grizzle; Lauren Babits; Courtney Clark; Ann M Taylor; Daniel C Malone
Journal:  J Am Med Inform Assoc       Date:  2010-12-03       Impact factor: 4.497

7.  Alert dwell time: introduction of a measure to evaluate interruptive clinical decision support alerts.

Authors:  Robert B McDaniel; Jonathan D Burlison; Donald K Baker; Murad Hasan; Jennifer Robertson; Christine Hartford; Scott C Howard; Andras Sablauer; James M Hoffman
Journal:  J Am Med Inform Assoc       Date:  2015-10-24       Impact factor: 4.497

8.  Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatients.

Authors:  Olesya I Zorina; Patrick Haueis; Waldemar Greil; Renate Grohmann; Gerd A Kullak-Ublick; Stefan Russmann
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

9.  Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.

Authors:  James E Tisdale; Heather A Jaynes; Joanna R Kingery; Brian R Overholser; Noha A Mourad; Tate N Trujillo; Richard J Kovacs
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-05-06

10.  Frequency of use of QT-interval prolonging drugs in psychiatry in Belgium.

Authors:  Eline Vandael; Thomas Marynissen; Johan Reyntens; Isabel Spriet; Joris Vandenberghe; Rik Willems; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.